Zurex Pharma, a Middleton, WI-based startup developing antimicrobial products to prevent hospital-acquired infections, has raised $4.1 million from investors in a round that could top out at $5.1 million, according to a new SEC filing.
There are 13 investors in the round, which appears to be the company’s Series B raise. Zurex officials couldn’t immediately be reached for comment.
Help employers find you! Check out all the jobs and post your resume.
